United States (US) PD-1/PD-L1 immunotherapy Market (2025-2031) Outlook | Analysis, Size, Value, Growth, Revenue, Share, Companies, Forecast, Industry & Trends

Name: United States (US) PD-1/PD-L1 immunotherapy Market (2025-2031) | Trends & Outlook Growth
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Type (CTLA-4 Inhibitor, PD-1 Inhibitor, PDL-1 Inhibitor, Others), By Application (Melanoma, Lung Cancer, Bladder Cancer, Others) And Competitive Landscape

Product Code: ETC070400	Publication Date: Jun 2021	Updated Date: Aug 2025	Product Type: Report
Publisher: 6Wresearch	Author: Ravi Bhandari	No. of Pages: 70	No. of Figures: 35	No. of Tables: 5

Key Highlights of the Report:

United States (US) PD-1/PD-L1 immunotherapy Market Outlook
Market Size of United States (US) PD-1/PD-L1 immunotherapy Market, 2021
Forecast of United States (US) PD-1/PD-L1 immunotherapy Market, 2031
Historical Data and Forecast of United States (US) PD-1/PD-L1 immunotherapy Revenues & Volume for the Period 2021 - 2031
United States (US) PD-1/PD-L1 immunotherapy Market Trend Evolution
United States (US) PD-1/PD-L1 immunotherapy Market Drivers and Challenges
United States (US) PD-1/PD-L1 immunotherapy Price Trends
United States (US) PD-1/PD-L1 immunotherapy Porter's Five Forces
United States (US) PD-1/PD-L1 immunotherapy Industry Life Cycle
Historical Data and Forecast of United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume By Type for the Period 2021 - 2031
Historical Data and Forecast of United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume By CTLA-4 Inhibitor for the Period 2021 - 2031
Historical Data and Forecast of United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume By PD-1 Inhibitor for the Period 2021 - 2031
Historical Data and Forecast of United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume By PDL-1 Inhibitor for the Period 2021 - 2031
Historical Data and Forecast of United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume By Others for the Period 2021 - 2031
Historical Data and Forecast of United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume By Application for the Period 2021 - 2031
Historical Data and Forecast of United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume By Melanoma for the Period 2021 - 2031
Historical Data and Forecast of United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume By Lung Cancer for the Period 2021 - 2031
Historical Data and Forecast of United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume By Bladder Cancer for the Period 2021 - 2031
Historical Data and Forecast of United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume By Others for the Period 2021 - 2031
United States (US) PD-1/PD-L1 immunotherapy Import Export Trade Statistics
Market Opportunity Assessment By Type
Market Opportunity Assessment By Application
United States (US) PD-1/PD-L1 immunotherapy Top Companies Market Share
United States (US) PD-1/PD-L1 immunotherapy Competitive Benchmarking By Technical and Operational Parameters
United States (US) PD-1/PD-L1 immunotherapy Company Profiles
United States (US) PD-1/PD-L1 immunotherapy Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) PD-1/PD-L1 immunotherapy Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) PD-1/PD-L1 immunotherapy Market - Industry Life Cycle

3.4 United States (US) PD-1/PD-L1 immunotherapy Market - Porter's Five Forces

3.5 United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume Share, By Form, 2021 & 2031F

4 United States (US) PD-1/PD-L1 immunotherapy Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in the United States

4.2.2 Growing adoption of immunotherapy as a preferred treatment option

4.2.3 Technological advancements in PD-1/PD-L1 therapies

4.3 Market Restraints

4.3.1 High cost associated with PD-1/PD-L1 immunotherapy

4.3.2 Stringent regulatory requirements for drug approval

4.3.3 Potential side effects and adverse reactions of immunotherapy

5 United States (US) PD-1/PD-L1 immunotherapy Market Trends

6 United States (US) PD-1/PD-L1 immunotherapy Market, By Types

6.1 United States (US) PD-1/PD-L1 immunotherapy Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume, By Type, 2018 - 2027F

6.1.3 United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume, By CTLA-4 Inhibitor, 2018 - 2027F

6.1.4 United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume, By PD-1 Inhibitor, 2018 - 2027F

6.1.5 United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume, By PDL-1 Inhibitor, 2018 - 2027F

6.1.6 United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume, By Others, 2018 - 2027F

6.2 United States (US) PD-1/PD-L1 immunotherapy Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume, By Melanoma, 2018 - 2027F

6.2.3 United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume, By Lung Cancer, 2018 - 2027F

6.2.4 United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume, By Bladder Cancer, 2018 - 2027F

6.2.5 United States (US) PD-1/PD-L1 immunotherapy Market Revenues & Volume, By Others, 2018 - 2027F

7 United States (US) PD-1/PD-L1 immunotherapy Market Import-Export Trade Statistics

7.1 United States (US) PD-1/PD-L1 immunotherapy Market Export to Major Countries

7.2 United States (US) PD-1/PD-L1 immunotherapy Market Imports from Major Countries

8 United States (US) PD-1/PD-L1 immunotherapy Market Key Performance Indicators

8.1 Patient response rate to PD-1/PD-L1 immunotherapy

8.2 Number of ongoing clinical trials for new PD-1/PD-L1 drugs

8.3 Adoption rate of PD-1/PD-L1 immunotherapy by healthcare providers

8.4 Average length of time for FDA approval of new PD-1/PD-L1 therapies

8.5 Investment in research and development for improving PD-1/PD-L1 treatments

9 United States (US) PD-1/PD-L1 immunotherapy Market - Opportunity Assessment

9.1 United States (US) PD-1/PD-L1 immunotherapy Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) PD-1/PD-L1 immunotherapy Market Opportunity Assessment, By Application, 2021 & 2031F

10 United States (US) PD-1/PD-L1 immunotherapy Market - Competitive Landscape

10.1 United States (US) PD-1/PD-L1 immunotherapy Market Revenue Share, By Companies, 2021

10.2 United States (US) PD-1/PD-L1 immunotherapy Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Asia Pacific PD-1/PD-L1 immunotherapy Market

Asia PD-1/PD-L1 immunotherapy Market

Europe PD-1/PD-L1 immunotherapy Market

Global PD-1/PD-L1 immunotherapy Market

Indonesia PD-1/PD-L1 immunotherapy Market

Malaysia PD-1/PD-L1 immunotherapy Market

Philippines PD-1/PD-L1 immunotherapy Market

Singapore PD-1/PD-L1 immunotherapy Market

Vietnam PD-1/PD-L1 immunotherapy Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here